🔎 Trials Near Me

Home › Mga Gulo sa Peripheral Nerve › New York

Pag-aaral pangklinika para sa Mga Gulo sa Peripheral Nerve sa New York

7 pag-aaral para sa Mga Gulo sa Peripheral Nerve ang naghahanap ng mga kalahok sa mga site sa New York.

Mga Lungsod sa New York

Opisyal na teksto ng pag-aaral (English)

Natural History Study for Charcot Marie Tooth Disease

  • Hereditary Neuropathy Foundation, New York
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Set 17, 2026 · NCT05902351

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

  • Ichan School of Medicine at Mount Sinai, New York
  • University of Rochester, Rochester
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06614322

Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer

  • Montefiore Medical Center, The Bronx
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT07109817

This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.

  • NYU Langone Health, New York
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT06616025

Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems

  • Dent Neurologic Institute, Amherst
Nagre-recruit
Edad 55 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT06959277

A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair

  • NYU Langone Orthopedic Center, New York
Nagre-recruit
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Hun 26, 2026 · NCT06529835

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

  • Start New York, LLC, Lake Success
  • MSK, New York
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 18, 2026 · NCT07484022

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.